Strategic investment in RemovAid AS

Bergen, Norway, 26th April 2024: Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), intend to invest NOK 2 million and become the majority shareholder in RemovAid AS, a medical technology company based in Oslo, Norway.

RemovAid is an ISO 13485 certified company who specializes in the development, manufacture and distribution of medical devices which remove subdermal implants. RemovAid has developed and patented an CE certified a class IIa medical device for gentle and efficient removal single-rod contraceptive implants.